
Sign up to save your podcasts
Or
In this week’s View, Dr. Eagle discusses the development and validation of the American Heart Association’s PREVENT risk assessment tool. He then explores implantable hemodynamic monitors and their role in improving survival in patients with heart failure and reduced ejection fraction. Finally, Dr. Eagle talks about the 10-year outcomes of the NOTION trial regarding transcatheter or surgical aortic valve implantation.
Subscribe to Eagle’s Eye View
4.7
125125 ratings
In this week’s View, Dr. Eagle discusses the development and validation of the American Heart Association’s PREVENT risk assessment tool. He then explores implantable hemodynamic monitors and their role in improving survival in patients with heart failure and reduced ejection fraction. Finally, Dr. Eagle talks about the 10-year outcomes of the NOTION trial regarding transcatheter or surgical aortic valve implantation.
Subscribe to Eagle’s Eye View
127 Listeners
315 Listeners
160 Listeners
853 Listeners
478 Listeners
31 Listeners
3,321 Listeners
91 Listeners
1,085 Listeners
51 Listeners
38 Listeners
175 Listeners
318 Listeners
414 Listeners
33 Listeners